Future Cardia, Inc
Developer of an under-skin implantable cardiac monitoring system intended for long-term monitoring of arrhythmia and heart-failure related physiology. The approach combines a short office insertion procedure, multi-sensor physiological sensing (ECG, heart sounds, chest motion, activity), extended battery life, and a data-driven monitoring platform intended to integrate with existing reimbursement pathways.
Industries
Nr. of Employees
small (1-50)
Future Cardia, Inc
2450 Holcombe Blvd Suite J, Houston, TX, 77021, US
Products
Subcutaneous long-term cardiac monitoring system
An implantable subcutaneous monitoring system that collects ECG, heart sounds, chest motion (seismocardiography) and activity data for longitudinal monitoring of arrhythmia and heart-failure related physiology.
Subcutaneous long-term cardiac monitoring system
An implantable subcutaneous monitoring system that collects ECG, heart sounds, chest motion (seismocardiography) and activity data for longitudinal monitoring of arrhythmia and heart-failure related physiology.
Services
Partnerships with hospitals, medical device companies and clinical key opinion leaders to support clinical evaluation, advisory input and NDA-level collaborations.
Partnerships with hospitals, medical device companies and clinical key opinion leaders to support clinical evaluation, advisory input and NDA-level collaborations.
Expertise Areas
- Implantable cardiac monitoring
- Multi-sensor physiological monitoring
- Cardiac electrophysiology monitoring (ECG/arrhythmia detection)
- Seismocardiography and phonocardiography for hemodynamic assessment
Key Technologies
- Electrocardiography (ECG)
- Phonocardiography (PCG)
- Seismocardiography (SCG)
- Accelerometer-based activity sensing
News & Updates
Press article referenced on the site regarding funding and company progress.
Company annual report and Form C-AR filings available on the SEC website.
Multiple clinical key opinion leaders and advisors listed as participating with the company.
Site text states an NDA was signed with a top hospital system and a top medical device company.
The site reports prior capital raised (noted as $11M previously raised and other fundraising references).
Press article referenced on the site regarding funding and company progress.
Company annual report and Form C-AR filings available on the SEC website.
Multiple clinical key opinion leaders and advisors listed as participating with the company.
Site text states an NDA was signed with a top hospital system and a top medical device company.
The site reports prior capital raised (noted as $11M previously raised and other fundraising references).